Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Rare Tumors|December 9, 2010
Chronic recurrent Gorham-Stout syndrome with cutaneous involvementJared Johnstun, Luther Brady, Rebecca Simstein, et al.International Journal of Radiation Oncology, Biology, Physics|December 19, 2012
Effect of fractionation in stereotactic body radiation therapy using the linear quadratic modelJun Yang, John Lamond, Jack Fowler, et al.Frontiers in Oncology|May 31, 2012
Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumorsRachelle Lanciano, John Lamond, Jun Yang, et al.Brachytherapy|November 23, 2011
Tumor bed-to-skin distance using accelerated partial-breast irradiation with the strut-adjusted volume implant deviceBrandon Fisher, Larry Daugherty, Talha Shaikh, et al.Frontiers in Oncology|May 23, 2015
SBRT: An Opportunity to Improve Quality of Life for Oligometastatic Prostate CancerGregory Azzam, Rachelle Lanciano, Steve Arrigo, et al.Journal of Radiation Oncology|March 17, 2015
Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective dosesNisha R Patel, Rachelle Lanciano, Karna Sura, et al.Frontiers in Oncology|December 7, 2016
Survival and Control Prognosticators of Recurrent Gynecological Malignancies of the Pelvis and Para-aortic Region Treated with Stereotactic Body Radiation TherapyShaakir Hasan, Anthony Ricco, Kaylette Jenkins, et al.Journal of Radiation Oncology|June 24, 2016
Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancerCaspian Oliai, Matthew Bernetich, Luther Brady, et al.Frontiers in Oncology|June 2, 2015
Salvage Fractionated Stereotactic Radiotherapy with or without Chemotherapy and Immunotherapy for Recurrent Glioblastoma Multiforme: A Single Institution ExperienceShaakir Hasan, Eda Chen, Rachelle Lanciano, et al.Frontiers in Oncology|September 8, 2016
The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk GroupsAnthony Ricco, Genevieve Manahan, Rachelle Lanciano, et al.Pageof 2